December 18, 2017 - The nuclear imaging equipment market is projected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8% during the forecast period, as a result of the introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new radiotracers, and increasing incidence of cancer and cardiovascular diseases, factors which are expected to drive the growth of the market.

By region, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to account for the largest share as in the forecast period of the nuclear imaging equipment market, followed by Asia-Pacific and Europe. Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. This can be attributed to aging population and increasing healthcare expenditure in Japan, developing healthcare infrastructure in China, and increasing adoption of nuclear imaging in India among others.

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

Source: http://bit.ly/2iCJtlN